September 26, 2018 Bio/Pharma/CRO Cell Analysis Tools M&A, Partnerships

Nanion Technologies places two SyncroPatch 384PE Instruments for Ion Channel Screening at Charles River Laboratories

https://www.nanion.de/images/Downloads_pdf/Press_Releases/180926_PR_Charles_River.pdf   Livingston, N.J., Munich, Germany, September 26, 2018: Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients. The instruments will be delivered to Charles... Read more

September 20, 2017 Cell Analysis Tools M&A, Partnerships

Cellular Dynamics International Signs Agreement with Nanion Technologies to Enhance Mutual Offerings for Researchers

Madison, Wisconsin, September 20, 2017— Cellular Dynamics International (CDI), a FUJIFILM company , the leading developer and manufacturer of differentiated cells derived from human induced pluripotent stem cells (iPSCs), and Nanion Technologies GmbH (Nanion), a leading provider of instrumentation for ion channel drug discovery and screening, announced today that they have entered into a joint marketing agreement. The... Read more